The effects of vagus nerve stimulation on tryptophan metabolites in children with intractable epilepsy - PubMed
Randomized Controlled Trial
doi: 10.1016/j.yebeh.2014.06.001. Epub 2014 Jul 10.
Affiliations
- PMID: 25022821
- DOI: 10.1016/j.yebeh.2014.06.001
Randomized Controlled Trial
The effects of vagus nerve stimulation on tryptophan metabolites in children with intractable epilepsy
S Klinkenberg et al. Epilepsy Behav. 2014 Aug.
Abstract
Background: The mechanism of action of vagus nerve stimulation (VNS) in intractable epilepsy is not entirely clarified. It is believed that VNS causes alterations in cytokines, which can lead to rebalancing the release of neurotoxic and neuroprotective tryptophan metabolites. We aimed to evaluate VNS effects on tryptophan metabolites and on epileptic seizures and investigated whether the antiepileptic effectiveness correlated with changes in tryptophan metabolism.
Methods: Forty-one children with intractable epilepsy were included in a randomized, active-controlled, double-blind study. After a baseline period of 12 weeks, all children underwent implantation of a vagus nerve stimulator and entered a blinded active-controlled phase of 20 weeks. Half of the children received high-output (therapeutic) stimulation (n=21), while the other half received low-output (active control) stimulation (n=20). Subsequently, all children received high-output stimulation for another 19 weeks (add-on phase). Tryptophan metabolites were assessed in plasma and cerebrospinal fluid (CSF) by use of liquid chromatography-tandem mass spectrometry (LC-MS/MS) and compared between high- and low-output groups and between the end of both study phases and baseline. Seizure frequency was recorded using seizure diaries. Mood was assessed using Profile of Mood States (POMS) questionnaires.
Results: Regarding tryptophan metabolites, anthranilic acid (AA) levels were significantly higher at the end of the add-on phase compared with baseline (p=0.002) and correlated significantly with improvement of mood (τ=-0.39, p=0.037) and seizure frequency reduction (τ=-0.33, p<0.01). No significant changes were found between high- and low-output groups regarding seizure frequency.
Conclusion: Vagus nerve stimulation induces a consistent increase in AA, a neuroprotective and anticonvulsant tryptophan metabolite. Moreover, increased AA levels are associated with improvement in mood and reduction of seizure frequency.
Keywords: Anthranilic acid; Kynurenine; Pediatric; Therapy-resistant seizures; Tryptophan metabolic pathway; VNS.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Klinkenberg S, van den Bosch CN, Majoie HJ, Aalbers MW, Leenen L, Hendriksen J, Cornips EM, Rijkers K, Vles JS, Aldenkamp AP. Klinkenberg S, et al. Eur J Paediatr Neurol. 2013 Jan;17(1):82-90. doi: 10.1016/j.ejpn.2012.07.003. Epub 2012 Aug 9. Eur J Paediatr Neurol. 2013. PMID: 22878130 Clinical Trial.
-
Vagus nerve stimulation in children with intractable epilepsy: a randomized controlled trial.
Klinkenberg S, Aalbers MW, Vles JS, Cornips EM, Rijkers K, Leenen L, Kessels FG, Aldenkamp AP, Majoie M. Klinkenberg S, et al. Dev Med Child Neurol. 2012 Sep;54(9):855-61. doi: 10.1111/j.1469-8749.2012.04305.x. Epub 2012 Apr 28. Dev Med Child Neurol. 2012. PMID: 22540141 Clinical Trial.
-
Aalbers MW, Klinkenberg S, Rijkers K, Verschuure P, Kessels A, Aldenkamp A, Vles J, Majoie M. Aalbers MW, et al. Neuroimmunomodulation. 2012;19(6):352-8. doi: 10.1159/000341402. Epub 2012 Oct 3. Neuroimmunomodulation. 2012. PMID: 23038102 Clinical Trial.
-
Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.
Chambers A, Bowen JM. Chambers A, et al. Ont Health Technol Assess Ser. 2013 Oct 1;13(18):1-37. eCollection 2013. Ont Health Technol Assess Ser. 2013. PMID: 24228081 Free PMC article. Review.
-
Vagus nerve stimulation: Surgical technique of implantation and revision and related morbidity.
Giordano F, Zicca A, Barba C, Guerrini R, Genitori L. Giordano F, et al. Epilepsia. 2017 Apr;58 Suppl 1:85-90. doi: 10.1111/epi.13678. Epilepsia. 2017. PMID: 28386925 Review.
Cited by
-
Surgical strategies for pediatric epilepsy.
Guan J, Karsy M, Ducis K, Bollo RJ. Guan J, et al. Transl Pediatr. 2016 Apr;5(2):55-66. doi: 10.21037/tp.2016.03.02. Transl Pediatr. 2016. PMID: 27186522 Free PMC article. Review.
-
A retrospective study of transcutaneous vagus nerve stimulation for poststroke epilepsy.
Song GF, Wang HY, Wu CJ, Li X, Yang FY. Song GF, et al. Medicine (Baltimore). 2018 Aug;97(31):e11625. doi: 10.1097/MD.0000000000011625. Medicine (Baltimore). 2018. PMID: 30075540 Free PMC article.
-
Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders.
Li D, Yu S, Long Y, Shi A, Deng J, Ma Y, Wen J, Li X, Liu S, Zhang Y, Wan J, Li N, Ao R. Li D, et al. Front Immunol. 2022 Sep 8;13:985378. doi: 10.3389/fimmu.2022.985378. eCollection 2022. Front Immunol. 2022. PMID: 36159806 Free PMC article. Review.
-
Vagus nerve stimulation for focal seizures.
Panebianco M, Rigby A, Marson AG. Panebianco M, et al. Cochrane Database Syst Rev. 2022 Jul 14;7(7):CD002896. doi: 10.1002/14651858.CD002896.pub3. Cochrane Database Syst Rev. 2022. PMID: 35833911 Free PMC article. Review.
-
Noninvasive Vagal Nerve Stimulation for Opioid Use Disorder.
Bremner JD, Gazi AH, Lambert TP, Nawar A, Harrison AB, Welsh JW, Vaccarino V, Walton KM, Jaquemet N, Mermin-Bunnell K, Mesfin H, Gray TA, Ross K, Saks G, Tomic N, Affadzi D, Bikson M, Shah AJ, Dunn KE, Giordano NA, Inan OT. Bremner JD, et al. Ann Depress Anxiety. 2023;10(1):1117. Epub 2023 Aug 2. Ann Depress Anxiety. 2023. PMID: 38074313 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical